RECOMMEND Platform Trial

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2029

Conditions
Extracorporeal Membrane Oxygenation ComplicationARDS (Acute Respiratory Distress Syndrome)Intensive Care MedicineCardiac Arrest (CA)Critical Illness
Interventions
OTHER

Liberal RBC Transfusion

Liberal transfusion trigger group (patient receives RBC transfusion if Hb \<90g/L).

OTHER

Restrictive RBC Transfusion

Restrictive transfusion trigger group (patient receives RBC transfusion if Hb \<70g/L).

Trial Locations (3)

2010

St. Vincent's Hospital Sydney, Sydney

2050

Royal Prince Alfred Hospital, Camperdown

3004

The Alfred Hospital, Melbourne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Monash University

OTHER

collaborator

Berry Consultants

OTHER

collaborator

Research Path

UNKNOWN

lead

Australian and New Zealand Intensive Care Research Centre

OTHER